Balance between science and nature
over 90 years of tradition and science

ro / eng

Imaginea 1

General presentation

Biofarm is one of the first Romanian manufacturers of medicines and food supplements.

For over 95 years and in joint effort with Romanian specialists, we've been on a race to discover the best solutions for maintaining people’s health.

Ever since its foundation in 1921, the company has focused on the development, manufacturing and marketing of both powerful brands and generic products.

Biofarm is currently one of the top 10 Romanian manufacturers in the highly dynamic and competitive Romanian pharmaceutical market. The company is certified to the international standard EN ISO 9001:2000 and in compliance with the Good Manufacturing Practice (GMP) Guideline for all its production lines.

Since 2005, the company's shares have been listed within Category I on the Bucharest Stock Exchange Category I.

For many years, Biofarm has been one of the top 3 Romanian leaders in manufacturing oral suspensions and solutions, the most important Romanian manufacturer of soft gelatine capsules, as well as one of the largest domestic producers of tablets and solid forms. The company owns high level research laboratories, modern production lines and a team of well trained experts.

Biofarm® is one of the first medicines and dietary supplements manufacturers in Romania. For over 90 years, in joint effort with Romanian specialists, Biofarm® has been on a race to discover the best solutions for maintaining and improving people’s health.

The company, founded in 1921, has focused on the development, manufacturing and marketing of strong brands and generic products.

Biofarm® is currently among the top 10 pharmaceutical manufacturers in the highly dynamic and competitive Romanian market. The company is certified to the international standard EN ISO 9001:2008 and in compliance with the Good Manufacturing Practice (GMP) Guideline for all its production lines. Also, starting with 2013 Biofarm has certified the environment and occupational health and safety integrated management system in accordance with the requirements of SR EN ISO 14001 standard and OHSAS 18001 specification. Since 2005, the company’s shares have been listed within Category I on the Bucharest Stock Exchange.

With its top research laboratories, modern production lines and a strong team of medical and sales representatives, Biofarm® is in top 3 Romanian manufacturers of solutions and suspensions for oral administration. 
Biofarm® is currently one of the most important soft gelatin capsules Romanian manufacturer, as well as one of the largest tablets and coated tablets domestic producers.

Biofarm has a competitive portfolio of over 200 products, covering 61 therapeutical areas and continuously invests in media, commercial and marketing campaigns in order to promote its own products.

Having reached a stable position on the Romanian market, Biofarm is planning to optimize its position within the international arena as well. Biofarm is currently present in 9 countries and is continuously expanding.

New products launching and portfolio improvement are key points of the company's development strategy. In order to boost its influence both on the domestic and international markets, Biofarm will develop and launch about 10 products every year.

Biofarm development strategy also includes improving the company presence on the retail market, further development of sales forces and an increase in the number of products. Its sustained investments in research, in launching and promoting its own products will help strengthen the company position on the market.

Biofarm® has a competitive portfolio of over 200 products, covering 61 therapeutical areas and invests continuously in media, commercial and marketing campaigns in order to promote its products.

Biofarm® has a strong position on the domestic market and aims to become an important player within the international arena as well. Biofarm® products are currently marketed in 10 countries: Armenia, Azerbaijan, Belarus, Kazakhstan, Lithuania, Moldavian Republic, Mongolia, Russia, Ukraine, Hungary and the expansion continues.

Launching new products and improving portfolio are key points of Biofarm®’s development strategy. In order to improve its position both on the domestic and international markets, Biofarm® will develop and launch approximately 10 products each year.

Biofarm®’s development strategy includes improving its presence on the retail market, extensive training of the sales force and extension of the product portfolio. Investments in research, launching and promoting its products will continue in order to improve the company’s position on the market.